Pembrolizumab and Lenvatinib in Patients With High Risk Locally Advanced Cervix Cancer

Clinical trial NCT07368985 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07368985
Sponsor: Prof. Dr. Remi A. Nout
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Cervical Cancer by FIGO Stage 2018 Squamous Cell Carcinoma FIGO 2018 Stage IIIA, IIIB, IIIC1-IIIC2 Adenocarcinoma or Adeno-squamous Carcinoma Stage IB3-IIIC2

Start date: 2026-03-01
Primary completion: 2029-10-01
Enrollment: 87

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.